Coastline Trust CO Amgen Inc Transaction History

Coastline Trust CO

  • $847 Million
  • Q3 2024

A detailed history of Coastline Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Coastline Trust CO holds 18,337 shares of AMGN stock, worth $5.14 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
18,337
Previous 18,338 0.01%
Holding current value
$5.14 Million
Previous $5.73 Million 3.12%
% of portfolio
0.7%
Previous 0.68%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$309.38 - $337.38 $309 - $337
-1 Reduced 0.01%
18,337 $5.91 Million
Q2 2024

Jul 15, 2024
SELL
$262.75 - $319.31 $208,886 - $253,851
-795 Reduced 4.16%
18,338 $5.73 Million
Q1 2024

Apr 26, 2024
SELL
$268.87 - $324.56 $51,891 - $62,640
-193 Reduced 1.0%
19,133 $5.44 Million
Q4 2023

Jan 23, 2024
SELL
$255.7 - $288.46 $5,114 - $5,769
-20 Reduced 0.1%
19,326 $5.57 Million
Q3 2023

Oct 17, 2023
SELL
$218.65 - $271.46 $381,325 - $473,426
-1,744 Reduced 8.27%
19,346 $5.2 Million
Q2 2023

Aug 07, 2023
SELL
$214.27 - $253.37 $194,985 - $230,566
-910 Reduced 4.14%
21,090 $4.68 Million
Q1 2023

May 31, 2023
SELL
$225.79 - $275.2 $31,610 - $38,528
-140 Reduced 0.63%
22,000 $5.32 Million
Q4 2022

Feb 09, 2023
SELL
$229.03 - $291.01 $75,350 - $95,742
-329 Reduced 1.46%
22,140 $5.81 Million
Q3 2022

Nov 03, 2022
SELL
$224.46 - $253.15 $36,586 - $41,263
-163 Reduced 0.72%
22,469 $5.06 Million
Q2 2022

Jul 22, 2022
SELL
$230.71 - $256.74 $140,733 - $156,611
-610 Reduced 2.62%
22,632 $5.51 Million
Q1 2022

May 04, 2022
SELL
$219.27 - $242.57 $6,578 - $7,277
-30 Reduced 0.13%
23,242 $5.62 Million
Q4 2021

Feb 10, 2022
SELL
$198.88 - $227.6 $13,523 - $15,476
-68 Reduced 0.29%
23,272 $5.24 Million
Q3 2021

Nov 09, 2021
BUY
$212.27 - $248.7 $266,611 - $312,367
1,256 Added 5.69%
23,340 $4.96 Million
Q2 2021

Aug 10, 2021
SELL
$233.58 - $259.14 $275,624 - $305,785
-1,180 Reduced 5.07%
22,084 $5.38 Million
Q1 2021

May 10, 2021
BUY
$221.91 - $258.6 $16,643 - $19,395
75 Added 0.32%
23,264 $5.79 Million
Q4 2020

Feb 12, 2021
BUY
$216.38 - $257.67 $42,194 - $50,245
195 Added 0.85%
23,189 $5.33 Million
Q3 2020

Oct 15, 2020
BUY
$234.65 - $260.95 $119,671 - $133,084
510 Added 2.27%
22,994 $5.84 Million
Q2 2020

Aug 07, 2020
SELL
$197.81 - $242.74 $1,978 - $2,427
-10 Reduced 0.04%
22,484 $5.3 Million
Q1 2020

Jun 10, 2020
SELL
$182.24 - $241.7 $55,583 - $73,718
-305 Reduced 1.34%
22,494 $4.56 Million
Q4 2019

Jan 15, 2020
BUY
$189.21 - $243.2 $287,599 - $369,664
1,520 Added 7.14%
22,799 $5.5 Million
Q3 2019

Oct 18, 2019
BUY
$174.11 - $208.62 $2,611 - $3,129
15 Added 0.07%
21,279 $4.12 Million
Q2 2019

Jul 18, 2019
BUY
$166.7 - $195.41 $148,196 - $173,719
889 Added 4.36%
21,264 $3.92 Million
Q1 2019

Apr 25, 2019
BUY
$180.87 - $203.88 $259,729 - $292,771
1,436 Added 7.58%
20,375 $3.87 Million
Q4 2018

Jan 15, 2019
SELL
$178.4 - $208.25 $7,314 - $8,538
-41 Reduced 0.22%
18,939 $3.69 Million
Q3 2018

Oct 17, 2018
BUY
$185.29 - $208.89 $243,656 - $274,690
1,315 Added 7.44%
18,980 $3.94 Million
Q2 2018

Jul 27, 2018
BUY
$166.05 - $186.51 $255,717 - $287,225
1,540 Added 9.55%
17,665 $3.26 Million
Q1 2018

Apr 16, 2018
BUY
$169.43 - $198.0 $319,375 - $373,230
1,885 Added 13.24%
16,125 $2.75 Million
Q4 2017

Jan 17, 2018
BUY
$168.79 - $188.59 $151,067 - $168,788
895 Added 6.71%
14,240 $2.48 Million
Q3 2017

Nov 17, 2017
BUY
$167.29 - $191.0 $342,108 - $390,595
2,045 Added 18.1%
13,345 $2.49 Million
Q2 2017

Aug 10, 2017
BUY
N/A
11,300
11,300 $1.95 Million

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Coastline Trust CO Portfolio

Follow Coastline Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastline Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Coastline Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email